GDC-0973 (Cobimetinib)

Catalog No. A11441

GDC-0973 (Cobimetinib,RG7420)是一种有效且高度选择性的MEK1抑制剂,IC50为4.2 nM,对MEK1的选择性选择性是对MEK2的100倍以上,并且当针对一组超过100个丝氨酸的抑制剂进行测试时,没有显示出明显的抑制作用。
  • Yunping Hu, .et al. FGFR1/MAPK-directed brachyury activation drives PD-L1-mediated immune evasion to promote lung cancer progression, Cancer Lett, 2022, Oct 28;547:215867 PMID: 35985510
  • Seidel D, .et al. A multidimensional impedance platform for the real-time analysis of single and combination drug pharmacology in patient-derived viable melanoma models, Biosens Bioelectron, 2019, Jan 1;123:185-194 PMID: 30201332
Catalog Num A11441
M. Wt 530.1
Formula C21H21F3IN3O2
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 934660-93-2
Synonyms XL518, XL 518, XL-518, RG7420
SMILES C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O
GDC-0973 (Cobimetinib,RG7420)是一种有效且高度选择性的MEK1抑制剂,IC50为4.2 nM,对MEK1的选择性选择性是对MEK2的100倍以上,并且当针对一组超过100个丝氨酸的抑制剂进行测试时,没有显示出明显的抑制作用。
Targets
MEK1
4.2 nM
In vitro (25°C) DMSO 88 mg/mL (165.62 mM)
Water Insoluble
Ethanol Warmed: 41 mg/mL (77.17 mM)
In vivo 5% DMSO+30% PEG 300+5% Tween 80+ddH2O 4 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 18.86 mL 94.32 mL 188.64 mL
0.5 mM 3.77 mL 18.86 mL 37.73 mL
1 mM 1.89 mL 9.43 mL 18.86 mL
5 mM 0.38 mL 1.89 mL 3.77 mL

*The above data is based on the productmolecular weight 530.1 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.